跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,928 条关于
“MetaVia Inc.”
全部
40,928
临床试验
11,232
药物
1,603
机构
6,168
资讯
21,925
去年
MetaVia's DA-1241 Shows Positive Phase 2a Results in MASH Patients
7个月前
MetaVia's AI-Driven Analysis Confirms Vanoglipel's Therapeutic Targets for MASH and Type 2 Diabetes
10个月前
MetaVia's DA-1726 Shows Promising Weight Loss Results in Phase 1 Trial with Superior Lipid Benefits
去年
MetaVia's DA-1241 Shows Enhanced Hepatoprotective Effects in MASH Combination Therapy
8个月前
MetaVia's DA-1726 Demonstrates 9.1% Weight Loss and Significant Metabolic Benefits in Phase 1b Obesity Trial
10个月前
MetaVia's Vanoglipel Shows Dual Benefits in MASH Phase 2a Trial with Significant HbA1c Reduction and Liver Improvements
去年
MetaVia's Novel Dual Receptor Agonist Shows Promising 6.3% Weight Loss in Phase 1 Obesity Trial
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
第 1 页,共 2193 页
上一页
下一页